The investment will focus on advancing HP's capabilities in microfluidics and microelectromechanical systems. The funding is expected to facilitate the manufacturing of silicon devices that are essential for life sciences lab equipment, which plays a vital role in areas such as drug discovery, single-cell research, and cell line development